the aid library

LIST OPTIONS

Filter

1634

Download (1721)

View PDF (2414)

Logistics of Health Care Waste Management

USAID (2009) CC

Information and Approaches for developing Country Settings

Download (202)

View PDF (224)

Consenso de recomendaciones de cuidados paliativos en la pandemia por SARS-Cov-2/COVID-19 - 2020

T. Fernández Dávil, P. A. Hidalgo Andrade, F. G. Torres Toala et al. El Gobierno des Todos, Ecuador (2020) CC

Consolidated recommendations for palliative care in the SARS pandemic-Cov-2/COVID-19 2020

External Link

Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) Country Report Gabon

Africa Center for Disease Control and Prevention (2023) CC

The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr... more

Download (317)

View PDF (556)

North-west Syria: Cross-border Humanitarian Response Fact Sheet (october 2022)

Office for the Coordination of Humanitarian Affairs OCHA (2022) C1

An 82 percent funding gap is putting the lives of 2.5 million people in north-west Syria at risk this winter. The first cholera case in north-west Syria was confirmed on 19 September. See below for the latest updates. On 17 September, at least six airstrikes were reported in Idleb, 10 ... more

External Link

Guidelines for the use of antimicrobials in the South African pig industry

Pig Veterinary Society of the South African Veterinary Association (2016) C2

Antimicrobial resistance(AMR) poses a serious threat to human, animal and environmental health. Implementing ethical practice guidelines on how to use antimicrobials effectively and responsibly within the pig industry will contribute in reducing and preventing antimicro... more

Download (2195)

View PDF (1202)

Completing the requisition and issue voucher_SOP

Ecumenical Pharmaceutical Network (EPN) (2011) C2

Last revised 2015. Original Word document on: http://www.epnetwork.org/Resources/Standard%20Operating%20Procedure/Requisition%20and%20issue%20voucher_SOP.doc

Download (426)

View PDF (1222)

Zika virus and the Olympic and Paralympic Games Rio 2016

World Health Organization WHO (2016) C_WHO

External Link

Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) Country Report Kenya

Africa Center for Disease Control and Prevention (2023) CC

Download (73)

View PDF (85)

Epidemiology and Challenges of Managing COPD in sub-Saharan Africa

Magitta, N.F.; Sciences, A. Acta Scientific Medical Sciences (2018) CC2

There is paucity of data on the burden and specific drivers operative in the pathogenesis of chronic obstructive pulmonary disease (COPD) in the African setting and populations. Lack of awareness and inadequate knowledge on the aetio-pathogenesis of the disease together with inadequate capacity for ... more

Download (96)

View PDF (95)

The Burden of Pediatric Asthma

Ferrante, G.; La Grutta, S. Frontiers in Pediatrics (2018) CC

Asthma is the most common chronic disease in children, imposing a consistent burden on health system. In recent years, prevalence of asthma symptoms became globally increased in children and adolescents, particularly in Low-Middle Income Countries (LMICs). Host (genetics, atopy) and environmental fa... more

Download (345)

View PDF (456)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (1194)

View PDF (1620)

Oxygen therapy for children: a manual for health workers
recommended

World Health Organization WHO (2016) C_WHO

This manual focuses on the availability and clinical use of oxygen therapy in children in health facilities by providing the practical aspects for health workers, biomedical engineers, and administrators. It addresses the need for appropriate detection of hypoxaemia, use of pulse oximetry, clinical ... more

Download (313)

View PDF (468)

Healthcare waste

USAID (2019) C1

Sector Environmental Guidelines, Full technical Update

Download (408)

View PDF (641)

Lesotho Nursing Initiative (poster)

Ministry of Health and Social Welfare MOHSW and the Clinton Health Access Initiative (CHAI) (2011) C2

Second Global Forum on Human Resources for Health 25 - 29 January 2011 | Bangkok, Thailand | Empower health workers for health outcomes | Reviewing progress, renewing commitments to health workers towards MDGs and beyond

External Link

Evaluation of drug promotional materials in a hospital setting in Nepal

Alam K., Shah A.K., Ojah P., et al. Southern Med Review (2009) C1

Southern Med Review (2009)2;1:2-6

Download (382)

View PDF (261)

ASHP Guidelines on Pharmacy-Prepared Ophthalmic Products

American Society of Hospital Pharmacists (ASHP) ASHP (2008) CC

Drug Distribution and Control: Preparation and Handling–Guidelines Review 2008

Download (154)

View PDF (175)

Job aid for COVID-19 vaccine administration: AZD1222 (‎ChAdOx1-S [‎recombinant]‎)‎ COVID-19 vaccine

World Health Organization WHO, Regional Office of Europe (2021) C_WHO

External Link

Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) Country Report Senegal

Africa Center for Disease Control and Prevention (2023) CC

Download (419)

View PDF (228)

Oxygénothérapie pour les enfants : manuel à l’usage des agents de santé

Organisation Mondiale de la Santé OMS (2017) C2

Download (413)

View PDF (312)

Оксигенотерапия у детей

World Health Organization WHO (2020) C2

Это руководство является частью серии, созданной для повышения качества лечения тяжело больных детей в медицинских учреждениях. Оно направлено на увеличение дост... more

Oxygen therapy for children: a manual for health workers recommended

Oxygen therapy for children: a manual for health workers
recommended